NERVGEN PHARMA CORP. (NGEN)
About NERVGEN PHARMA CORP. (NGEN)
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.
- 9
- 2019
- XNAS
90-Day SEC Filing Activity
No Form 4 activity for NGEN in the last 90 days.
NGEN Insider Transactions (Form 4)
0No Form 4 filings for NGEN yet.
Transactions appear here automatically as insiders file with the SEC.
NGEN Insider Trading - FAQ
Where can I see NGEN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks NGEN Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow NGEN insider buys?
Create a free InsiderAlpha account and press Watch on this page to add NGEN to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where NGEN's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track NGEN insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
